ORCHESTRA BIOMED HLDGS INC
OBIO·68572M106·US·Common Stock·Healthcare - Biotechnology-Activist
OBIO (ORCHESTRA BIOMED HLDGS INC) is held by 39 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($35.3M), VANGUARD CAPITAL MANAGEMENT LLC ($9.4M), Alyeska Investment Group, L.P. ($4.3M). Net institutional sentiment: Mixed.
39
Holders
Avg rating(6 Elite)
$65.9M
Total Value
53% (51)
Fund Consensus
25 buying - 22 selling
Who's Trading
InsiderAJAryeh JasonBuy $2KMay 18, 2026
InsiderHPHochman David PBuy $19KMay 15, 2026
InsiderAJAryeh JasonBuy $35KMay 15, 2026
InsiderFSFain Eric SBuy $83KMay 14, 2026
InsiderRLRTW INVESTMENTS, LPSell $132.16Apr 27, 2026
InsiderHPHochman David PBuy $43KMar 13, 2026
ActivistMPMedtronic plc17.8%Feb 27, 2026
ActivistTATasso Partners, LLC5.0%Nov 19, 2025
InsiderHPHochman David PBuy $20KNov 14, 2025
13F: Insider & Congress:
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer